Qiagen N.V. Company Profile (NASDAQ:QGEN)

About Qiagen N.V. (NASDAQ:QGEN)

Qiagen N.V. logoQIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:QGEN
  • CUSIP: N7248210
  • Web: www.qiagen.com
Capitalization:
  • Market Cap: $7.25553 billion
  • Outstanding Shares: 228,233,000
Average Prices:
  • 50 Day Moving Avg: $31.87
  • 200 Day Moving Avg: $31.77
  • 52 Week Range: $24.89 - $35.26
P/E:
  • Trailing P/E Ratio: 98.44
  • Foreward P/E Ratio: 22.83
  • P/E Growth: 1.92
Sales & Book Value:
  • Annual Revenue: $1.36 billion
  • Price / Sales: 5.40
  • Book Value: $10.98 per share
  • Price / Book: 2.93
Profitability:
  • EBIDTA: $443.36 million
  • Net Margins: 5.44%
  • Return on Equity: 11.04%
  • Return on Assets: 6.53%
Debt:
  • Debt-to-Equity Ratio: 0.55%
  • Current Ratio: 3.85%
  • Quick Ratio: 3.34%
Misc:
  • Average Volume: 901,241 shs.
  • Beta: 1.15
  • Short Ratio: 3.51
 

Frequently Asked Questions for Qiagen N.V. (NASDAQ:QGEN)

What is Qiagen N.V.'s stock symbol?

Qiagen N.V. trades on the NASDAQ under the ticker symbol "QGEN."

How were Qiagen N.V.'s earnings last quarter?

Qiagen N.V. (NASDAQ:QGEN) announced its quarterly earnings results on Thursday, July, 27th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.28 by $0.02. The company earned $349 million during the quarter, compared to analyst estimates of $353.09 million. Qiagen N.V. had a return on equity of 11.04% and a net margin of 5.44%. The firm's quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.24 EPS. View Qiagen N.V.'s Earnings History.

When will Qiagen N.V. make its next earnings announcement?

Qiagen N.V. is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for Qiagen N.V..

What guidance has Qiagen N.V. issued on next quarter's earnings?

Qiagen N.V. updated its FY17 earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $1.25-1.27 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.25.

Where is Qiagen N.V.'s stock going? Where will Qiagen N.V.'s stock price be in 2017?

12 analysts have issued 12-month target prices for Qiagen N.V.'s stock. Their forecasts range from $27.00 to $37.00. On average, they expect Qiagen N.V.'s share price to reach $32.56 in the next year. View Analyst Ratings for Qiagen N.V..

Who are some of Qiagen N.V.'s key competitors?

Who are Qiagen N.V.'s key executives?

Qiagen N.V.'s management team includes the folowing people:

  • Manfred E. Karobath, Chairman of the Supervisory Board
  • Peer M. Schatz, Chief Executive Officer, Managing Director
  • Roland Sackers, Chief Financial Officer
  • Thomas Schweins, Senior Vice President - Human Resources, Strategy & Marketing Services
  • Thierry Bernard, Senior Vice President - Molecular Diagnostics Business Area
  • Laura Furmanski, Senior Vice President - Bioinformatics Business Area
  • Douglas Liu, Senior Vice President - Global Operations
  • Manuel O. Mendez, Senior Vice President - Global Commercial Operations
  • Stephane Bancel, Independent Supervisory Director
  • Hakan Bjorklund, Supervisory Board Director

Who owns Qiagen N.V. stock?

Qiagen N.V.'s stock is owned by many different of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (8.94%), BlackRock Inc. (3.59%), Baillie Gifford & Co. (3.14%), Vanguard Group Inc. (2.65%), Johnston Asset Management LLC (1.59%) and Manning & Napier Advisors LLC (1.34%). View Institutional Ownership Trends for Qiagen N.V..

Who sold Qiagen N.V. stock? Who is selling Qiagen N.V. stock?

Qiagen N.V.'s stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Balyasny Asset Management LLC, Douglas Lane & Associates LLC, Manning & Napier Advisors LLC, Harris Associates L P, AXA, Canada Pension Plan Investment Board and Platinum Investment Management Ltd.. View Insider Buying and Selling for Qiagen N.V..

Who bought Qiagen N.V. stock? Who is buying Qiagen N.V. stock?

Qiagen N.V.'s stock was purchased by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Los Angeles Capital Management & Equity Research Inc., WINTON GROUP Ltd, Exane Asset Management, Atlanta Capital Management Co. L L C, Vanguard Group Inc., BlackRock Inc. and Neuberger Berman Group LLC. View Insider Buying and Selling for Qiagen N.V..

How do I buy Qiagen N.V. stock?

Shares of Qiagen N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Qiagen N.V.'s stock price today?

One share of Qiagen N.V. stock can currently be purchased for approximately $32.19.


MarketBeat Community Rating for Qiagen N.V. (NASDAQ QGEN)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  230 (Vote Outperform)
Underperform Votes:  321 (Vote Underperform)
Total Votes:  551
MarketBeat's community ratings are surveys of what our community members think about Qiagen N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Qiagen N.V. (NASDAQ:QGEN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.42)
Consensus Price Target: $32.56 (1.16% upside)

Analysts' Ratings History for Qiagen N.V. (NASDAQ:QGEN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/28/2017DZ Bank AGReiterated RatingNeutralLowView Rating Details
8/17/2017Commerzbank AgReiterated RatingBuyLowView Rating Details
8/14/2017Cowen and CompanyReiterated RatingHold$33.00LowView Rating Details
8/1/2017Independent Research GmbHUpgradeSell -> HoldLowView Rating Details
7/31/2017Jefferies Group LLCReiterated RatingHold$25.00 -> $28.00LowView Rating Details
7/31/2017Deutsche Bank AGReiterated RatingBuyLowView Rating Details
7/21/2017Bank of America CorporationReiterated RatingNeutral$33.00 -> $36.00LowView Rating Details
7/17/2017Barclays PLCReiterated RatingOverweight$33.00 -> $37.00LowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingMarket Perform$28.00 -> $31.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingOverweight$36.00 -> $37.00LowView Rating Details
5/4/2017Evercore ISIBoost Price TargetOutperform$30.00 -> $31.50HighView Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$27.00N/AView Rating Details
8/1/2016HSBC Holdings plcUpgradeHold -> BuyN/AView Rating Details
8/1/2016MizuhoBoost Price TargetNeutral$22.00 -> $25.00N/AView Rating Details
7/25/2016Piper Jaffray CompaniesReiterated RatingNeutral$23.00N/AView Rating Details
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00N/AView Rating Details
11/12/2015Stifel NicolausInitiated CoverageHoldN/AView Rating Details
10/30/2015Goldman Sachs Group, Inc. (The)Lower Price Target$22.00 -> $21.00N/AView Rating Details
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00N/AView Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for Qiagen N.V. (NASDAQ:QGEN)
Earnings by Quarter for Qiagen N.V. (NASDAQ:QGEN)
Earnings History by Quarter for Qiagen N.V. (NASDAQ QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017$0.32N/AView Earnings Details
7/27/20176/30/2017$0.28$0.30$353.09 million$349.00 millionViewN/AView Earnings Details
2/1/2017Q416$0.34$0.39$372.70 million$366.50 millionViewListenView Earnings Details
11/2/2016Q316$0.28$0.29$335.46 million$338.70 millionViewN/AView Earnings Details
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details
7/24/2012$0.25$0.25ViewN/AView Earnings Details
4/25/2012$0.21$0.23ViewN/AView Earnings Details
1/31/2012$0.28$0.31ViewN/AView Earnings Details
11/2/2011$0.22$0.24ViewN/AView Earnings Details
7/25/2011$0.23$0.23ViewN/AView Earnings Details
4/27/2011$0.21$0.21ViewN/AView Earnings Details
1/31/2011$0.25$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Qiagen N.V. (NASDAQ:QGEN)
2017 EPS Consensus Estimate: $1.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.18$0.18$0.18
Q2 20171$0.29$0.29$0.29
Q3 20171$0.31$0.31$0.31
Q4 20171$0.42$0.42$0.42
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen N.V. (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen N.V. (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Qiagen N.V. (NASDAQ:QGEN)
Latest Headlines for Qiagen N.V. (NASDAQ:QGEN)
Source:
DateHeadline
americanbankingnews.com logoReviewing Qiagen N.V. (QGEN) & Its Rivals
www.americanbankingnews.com - September 21 at 8:52 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Expected to Announce Earnings of $0.32 Per Share
www.americanbankingnews.com - September 20 at 6:12 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - September 12 at 8:42 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Expected to Post Quarterly Sales of $365.10 Million
www.americanbankingnews.com - September 3 at 4:00 AM
americanbankingnews.com logo$0.32 EPS Expected for Qiagen N.V. (QGEN) This Quarter
www.americanbankingnews.com - September 1 at 6:24 PM
americanbankingnews.com logoQiagen N.V. (QGEN) Earns Neutral Rating from DZ Bank AG
www.americanbankingnews.com - August 28 at 10:16 AM
nasdaq.com logoQIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer
www.nasdaq.com - August 22 at 6:07 AM
americanbankingnews.com logoCommerzbank Ag Reiterates "Buy" Rating for Qiagen N.V. (QGEN)
www.americanbankingnews.com - August 20 at 5:02 PM
nasdaq.com logoAbbott-North West London Pathology Expand in Diagnostics - Nasdaq
www.nasdaq.com - August 17 at 7:12 AM
americanbankingnews.com logoZacks: Analysts Anticipate Qiagen N.V. (QGEN) Will Announce Quarterly Sales of $365.10 Million
www.americanbankingnews.com - August 16 at 7:16 AM
finance.yahoo.com logoQIAGEN NV – Value Analysis (NASDAQ:QGEN) : August 14, 2017
finance.yahoo.com - August 15 at 6:33 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Earns Hold Rating from Cowen and Company
www.americanbankingnews.com - August 14 at 4:18 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Qiagen NV.
finance.yahoo.com - August 11 at 7:51 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Cut to "Hold" at BidaskClub
www.americanbankingnews.com - August 4 at 8:39 PM
americanbankingnews.com logoQiagen N.V. Forecasted to Earn FY2019 Earnings of $1.54 Per Share (NASDAQ:QGEN)
www.americanbankingnews.com - August 2 at 4:58 PM
americanbankingnews.com logoQiagen N.V. (QGEN) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - August 1 at 3:22 PM
americanbankingnews.com logoWilliam Blair Analysts Cut Earnings Estimates for Qiagen N.V. (NASDAQ:QGEN)
www.americanbankingnews.com - August 1 at 2:44 PM
americanbankingnews.com logoQiagen N.V. (QGEN) Upgraded to "Hold" by Independent Research GmbH
www.americanbankingnews.com - August 1 at 11:08 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for Qiagen N.V. (NASDAQ:QGEN) Cut by Analyst
www.americanbankingnews.com - August 1 at 7:40 AM
finance.yahoo.com logoQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 31, 2017
finance.yahoo.com - August 1 at 5:05 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Receives Hold Rating from Jefferies Group LLC
www.americanbankingnews.com - July 31 at 7:56 PM
americanbankingnews.com logoZacks: Brokerages Expect Qiagen N.V. (NASDAQ:QGEN) Will Post Quarterly Sales of $355.59 Million
www.americanbankingnews.com - July 29 at 10:58 AM
americanbankingnews.com logoTheStreet Lowers Qiagen N.V. (NASDAQ:QGEN) to C+
www.americanbankingnews.com - July 29 at 9:54 AM
nasdaq.com logoQIAGEN (QGEN) Beats on Earnings & Sales in Q2, Raises View - Nasdaq
www.nasdaq.com - July 29 at 6:36 AM
finance.yahoo.com logoEdited Transcript of QGEN earnings conference call or presentation 28-Jul-17 1:00pm GMT
finance.yahoo.com - July 29 at 6:36 AM
finance.yahoo.com logoQIAGEN Reports Results for Second Quarter and First Half of 2017
finance.yahoo.com - July 28 at 7:06 AM
finance.yahoo.com logoQiagen beats Street 2Q forecasts
finance.yahoo.com - July 28 at 7:06 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Earns "Buy" Rating from Commerzbank Ag
www.americanbankingnews.com - July 28 at 6:36 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS
www.americanbankingnews.com - July 27 at 3:00 PM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Releases FY17 Earnings Guidance
www.americanbankingnews.com - July 27 at 3:00 PM
americanbankingnews.com logo Analysts Anticipate Qiagen N.V. (NASDAQ:QGEN) to Post $0.28 EPS
www.americanbankingnews.com - July 27 at 10:35 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - July 24 at 10:37 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Stock Rating Reaffirmed by Bank of America Corporation
www.americanbankingnews.com - July 21 at 9:30 AM
streetinsider.com logoQiagen NV (QGEN) PT Raised to $37 at Barclays on 2Q Preview; 'Differentiated Growth Profile Relative to Peers' - StreetInsider.com
www.streetinsider.com - July 18 at 7:43 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Given "Overweight" Rating at Barclays PLC
www.americanbankingnews.com - July 17 at 10:20 PM
americanbankingnews.com logoQiagen N.V.'s (NASDAQ:QGEN) "Market Perform" Rating Reaffirmed at Wells Fargo & Co
www.americanbankingnews.com - July 13 at 9:02 PM
finance.yahoo.com logoQIAGEN N.V. to Report Second Quarter and First Half of 2017 Results
finance.yahoo.com - July 13 at 8:27 AM
americanbankingnews.com logoQiagen N.V. (QGEN) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - July 12 at 6:34 PM
americanbankingnews.com logoMorgan Stanley Reaffirms "Overweight" Rating for Qiagen N.V. (QGEN)
www.americanbankingnews.com - July 10 at 10:20 PM
finance.yahoo.com logoQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 7, 2017
finance.yahoo.com - July 8 at 1:51 PM
finance.yahoo.com logoETFs with exposure to QIAGEN NV : July 5, 2017
finance.yahoo.com - July 6 at 8:16 AM
finance.yahoo.com logoETFs with exposure to QIAGEN NV : July 5, 2017
finance.yahoo.com - July 6 at 8:16 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Downgraded by BidaskClub
www.americanbankingnews.com - July 5 at 6:20 PM
americanbankingnews.com logoQiagen N.V. (QGEN) Expected to Announce Quarterly Sales of $347.27 Million
www.americanbankingnews.com - July 2 at 7:44 AM
americanbankingnews.com logoQiagen N.V. (NASDAQ:QGEN) Expected to Announce Earnings of $0.28 Per Share
www.americanbankingnews.com - June 30 at 10:43 PM
americanbankingnews.com logoQiagen N.V. (QGEN) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - June 27 at 9:04 AM
streetinsider.com logoQiagen (QGEN) Says French Health System Approves Reimbursement of QuantiFERON Latent TB Test
www.streetinsider.com - June 23 at 8:14 PM
americanbankingnews.com logoQiagen N.V.'s (QGEN) Buy Rating Reaffirmed at Commerzbank Ag
www.americanbankingnews.com - June 23 at 1:58 PM
streetinsider.com logoQiagen (QGEN) Says French Health System Approves Reimbursement of QuantiFERON Latent TB Test - StreetInsider.com
www.streetinsider.com - June 23 at 9:22 AM
finance.yahoo.com logoETFs with exposure to QIAGEN NV : June 22, 2017
finance.yahoo.com - June 23 at 9:22 AM

Social

Chart

Qiagen N.V. (QGEN) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff